The announcement of the pairing comes several months after Adare Pharma Solutions said it would upgrade several of its facilities, including in Milan, Italy, where the 3D printing operations will be ...

TUS+VEN+AZA Triplet Frontline Therapy in Newly Diagnosed AML Patients Now Enrolling at U.S. SitesTUS and TUS+VEN Broadly Active Across AML ...

prior-HMA TUS once daily orally as a single agent achieved CR/CRh responses at four different dose levels (40, 80, 120, and 160 mg) with no dose limiting toxicities (no DLTs) TUS showed a favorable ...

The majority of caregivers of patients with tuberous sclerosis complex (TSC) planned to continue Epidiolex treatment, citing ...

Odronextamab monotherapy led to complete responses in all patients with previously untreated follicular lymphoma evaluable for efficacy, per ...

Acrivon Therapeutics develops innovative cancer therapies with companion diagnostics. Read why ACRV stock has upside ...

Occasionally, some patients require a different dosage of a medication than the dosages commercially available in patch form. Alteration of a TDDS (i.e., cutting the patch to reduce the surface ...

End it for Good is a nonprofit dedicated to promoting alternative treatments for addiction. Leaders say about 17% of all ...

U.N. experts say there has been a slight drop in the production of opium in Myanmar, the world’s biggest source of the ...

Transcenta Holding Limited, announced late-breaking presentation of preclinical study results of novel humanized LIV-1 ...

Dr David Stamler - CEO - Alterity Therapeutics Limited (ASX:ATH) is developing first-in-class therapies to treat ...

Dougal Ferguson - CEO - TMK Energy Limited’s (ASX:TMK) flagship project, the Gurvantes XXXV Project, is a comprehensive Coal ...